Unique ID issued by UMIN | UMIN000021397 |
---|---|
Receipt number | R000024679 |
Scientific Title | Evaluation of Duodenal Mucosal Admittance Index in Patients with Functional Dyspepsia (FD) |
Date of disclosure of the study information | 2016/03/31 |
Last modified on | 2019/03/16 16:01:42 |
Evaluation of Duodenal Mucosal Admittance Index in Patients with Functional Dyspepsia (FD)
Evaluation of Duodenal Mucosal Admittance Index in Patients with Functional Dyspepsia (FD)
Evaluation of Duodenal Mucosal Admittance Index in Patients with Functional Dyspepsia (FD)
Evaluation of Duodenal Mucosal Admittance Index in Patients with Functional Dyspepsia (FD)
Japan |
Functional dyspepsia
Gastroenterology |
Others
NO
Evaluation of duodenal mucosal admittance index in FD patients
Safety,Efficacy
Duodenal mucosal admittance index of FD patients and healthy subjects
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Prevention
Device,equipment |
Tissue Conductance Meter
20 | years-old | <= |
Not applicable |
Male and Female
1. Patients who are diagnosed functional dyspepsia by Rome III criteria.
2. Patients who are older than 20 years old.
3. Patients from whom written informed consent is obtained.
1.Patients who have a history of pacemaker or ICD implantation.
2. Patients who have a history of electrical device implantation to brain such as deep brain stimulation.
3. Patients whose conditions are likely to cause upper abdominal symptoms such as malignant tumors, peptic ulcers, and systemic diseases (neurological diseases including Parkinson's disease, metabolic diseases including diabetes, etc.).
4. Patients with predominant GERD.
5. Patients who are suspicious for IBS.
6. Patients who have a history of upper gastrointestinal tract operation.
7. Patients who have a history of brain structural disease including schizophrenia, and depression.
8. Patients who have severe disorder of cardiovascular, liver or renal function, infection, and hematopoietic organ.
9. Patients who are taking aspirin, NSAIDs, corticosteroids or other immunosuppressive drugs.
10. Patients whose causes of dyspepsia are considered excessive drinking, overeating, and severe stress.
11. Patients who are alcohol or drug dependent.
12. Pregnancy or lactation woman. Patients who hope pregnancy during study.
13. Patients who took H. pylori eradication therapy within 6 months.
14. Patients who are judged as being inappropriate for this study by their medical doctor.
50
1st name | |
Middle name | |
Last name | Makoto Arai |
Chiba University Hospital
Gastroenterology
1-8-1, Inohana, Chuo-ku, Chib acity, Chiba prefecture, Japan
043-226-2083
araim-cib@umin.ac.jp
1st name | |
Middle name | |
Last name | Hideaki Ishigami |
Chiba University Hospital
Gastroenterology
1-8-1, Inohana, Chuo-ku, Chib acity, Chiba prefecture, Japan
043-226-2083
ishigami-ncu@umin.ac.jp
Chiba University
Chiba University
Self funding
NO
2016 | Year | 03 | Month | 31 | Day |
Unpublished
Completed
2015 | Year | 06 | Month | 30 | Day |
2015 | Year | 06 | Month | 30 | Day |
2015 | Year | 07 | Month | 01 | Day |
2017 | Year | 03 | Month | 31 | Day |
2016 | Year | 03 | Month | 08 | Day |
2019 | Year | 03 | Month | 16 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000024679
Research Plan | |
---|---|
Registered date | File name |
2017/09/09 | 2298計画書.docx |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |